What are the advantages of using nanoparticles for PD-L1 targeting?
The use of nanoparticles for PD-L1 targeting offers several advantages: - Enhanced permeability and retention effect (EPR), allowing nanoparticles to accumulate more in tumor tissues. - Improved drug solubility and stability. - Controlled and sustained release of therapeutic agents. - Reduced systemic toxicity and side effects. - Possibility of co-delivering multiple therapeutic agents for synergistic effects.
